03 Dec 2020 Galapagos announces first dosing in MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease Member news
02 Dec 2020 eTheRNA and China Grand Pharma enter a strategic collaboration in the Greater China Region focussed on eTheRNA’s proprietary mRNA development products and manufacturing capabilities Member news
02 Dec 2020 AbolerIS Pharma signed with Ouest Valorisation an exclusive world-wide license to develop new first-in-class anti-CD45RC monoclonal antibodies Member news
01 Dec 2020 atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer Member news
01 Dec 2020 Galapagos reports positive topline results with GLPG1205 in IPF patients in PINTA Proof-of-Concept trial Member news
01 Dec 2020 Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers Member news
25 Nov 2020 Estetrol recognized as a "New Active Substance" by the European Medicines Agency (EMA) Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
